This study is testing a treatment for hip osteoarthritis (OA) that uses your own cells. It involves injections of StroMed and Platelet Rich Plasma (PRP) directly into your affected hip joint. Researchers want to see if this treatment can reduce pain and inflammation. They will measure success by tracking your hip pain and function using questionnaires (HOOS survey) over six months. You might be able to join if you are between 18 and 90 years old, have hip OA, and can follow the study plan. The study is currently unclear on its recruitment status and plans to enroll 4000 participants.

Study design

This is an open-label study, meaning both you and the researchers will know what treatment you are receiving. It will initially involve 50 patients, with a larger follow-up planned for 4,000 patients.

What's involved

You will receive injections into your hip joint. You will also have laboratory tests, periodic interviews, and MRI scans up to six months, along with completing questionnaires.

Compensation

Not stated in the trial record.

Follow-up

Your progress will be followed for up to six months after the initial treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.